Logo image of DEA

EASTERLY GOVERNMENT PROPERTI (DEA) Stock Fundamental Analysis

NYSE:DEA - New York Stock Exchange, Inc. - US27616P3010 - REIT - Currency: USD

23.24  +0.13 (+0.56%)

After market: 23.24 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to DEA. DEA was compared to 130 industry peers in the Diversified REITs industry. While DEA is still in line with the averages on profitability rating, there are concerns on its financial health. DEA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year DEA was profitable.
DEA had a positive operating cash flow in the past year.
In the past 5 years DEA has always been profitable.
DEA had a positive operating cash flow in each of the past 5 years.
DEA Yearly Net Income VS EBIT VS OCF VS FCFDEA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

1.2 Ratios

DEA has a Return On Assets (0.54%) which is in line with its industry peers.
DEA's Return On Equity of 1.31% is in line compared to the rest of the industry. DEA outperforms 50.39% of its industry peers.
DEA has a worse Return On Invested Capital (2.04%) than 65.89% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DEA is in line with the industry average of 3.16%.
The 3 year average ROIC (1.98%) for DEA is below the current ROIC(2.04%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.54%
ROE 1.31%
ROIC 2.04%
ROA(3y)0.77%
ROA(5y)0.77%
ROE(3y)1.77%
ROE(5y)1.72%
ROIC(3y)1.98%
ROIC(5y)1.97%
DEA Yearly ROA, ROE, ROICDEA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.5 1 1.5 2

1.3 Margins

With a Profit Margin value of 5.66%, DEA perfoms like the industry average, outperforming 53.49% of the companies in the same industry.
DEA's Profit Margin has improved in the last couple of years.
DEA has a Operating Margin (26.33%) which is comparable to the rest of the industry.
DEA's Operating Margin has improved in the last couple of years.
DEA has a Gross Margin of 66.87%. This is comparable to the rest of the industry: DEA outperforms 51.16% of its industry peers.
DEA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.33%
PM (TTM) 5.66%
GM 66.87%
OM growth 3Y-0.6%
OM growth 5Y9.25%
PM growth 3Y-16.41%
PM growth 5Y14.45%
GM growth 3Y-0.86%
GM growth 5Y-0.31%
DEA Yearly Profit, Operating, Gross MarginsDEA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DEA is destroying value.
The number of shares outstanding for DEA has been increased compared to 1 year ago.
Compared to 5 years ago, DEA has more shares outstanding
DEA has a worse debt/assets ratio than last year.
DEA Yearly Shares OutstandingDEA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
DEA Yearly Total Debt VS Total AssetsDEA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

DEA has an Altman-Z score of 0.25. This is a bad value and indicates that DEA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.25, DEA is doing worse than 65.12% of the companies in the same industry.
The Debt to FCF ratio of DEA is 548.14, which is on the high side as it means it would take DEA, 548.14 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DEA (548.14) is comparable to the rest of the industry.
DEA has a Debt/Equity ratio of 1.20. This is a high value indicating a heavy dependency on external financing.
DEA has a Debt to Equity ratio of 1.20. This is comparable to the rest of the industry: DEA outperforms 51.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.2
Debt/FCF 548.15
Altman-Z 0.25
ROIC/WACC0.32
WACC6.48%
DEA Yearly LT Debt VS Equity VS FCFDEA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

DEA has a Current Ratio of 0.87. This is a bad value and indicates that DEA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.87, DEA perfoms like the industry average, outperforming 46.51% of the companies in the same industry.
A Quick Ratio of 0.87 indicates that DEA may have some problems paying its short term obligations.
DEA has a Quick ratio (0.87) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.87
DEA Yearly Current Assets VS Current LiabilitesDEA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

The earnings per share for DEA have decreased strongly by -16.00% in the last year.
DEA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.70% yearly.
The Revenue has been growing slightly by 6.62% in the past year.
DEA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.38% yearly.
EPS 1Y (TTM)-16%
EPS 3Y-18.42%
EPS 5Y13.7%
EPS Q2Q%-44%
Revenue 1Y (TTM)6.62%
Revenue growth 3Y3.19%
Revenue growth 5Y6.38%
Sales Q2Q%8.07%

3.2 Future

Based on estimates for the next years, DEA will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.18% on average per year.
Based on estimates for the next years, DEA will show a small growth in Revenue. The Revenue will grow by 7.62% on average per year.
EPS Next Y15.35%
EPS Next 2Y22.87%
EPS Next 3Y14.18%
EPS Next 5YN/A
Revenue Next Year9.31%
Revenue Next 2Y8.93%
Revenue Next 3Y8.49%
Revenue Next 5Y7.62%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
DEA Yearly Revenue VS EstimatesDEA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
DEA Yearly EPS VS EstimatesDEA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 55.33 indicates a quite expensive valuation of DEA.
The rest of the industry has a similar Price/Earnings ratio as DEA.
The average S&P500 Price/Earnings ratio is at 27.41. DEA is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 32.41 indicates a quite expensive valuation of DEA.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DEA indicates a somewhat cheap valuation: DEA is cheaper than 73.64% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.19, DEA is valued at the same level.
Industry RankSector Rank
PE 55.33
Fwd PE 32.41
DEA Price Earnings VS Forward Price EarningsDEA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DEA is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as DEA.
Industry RankSector Rank
P/FCF 357.23
EV/EBITDA 14.61
DEA Per share dataDEA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
DEA has a very decent profitability rating, which may justify a higher PE ratio.
DEA's earnings are expected to grow with 14.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.6
PEG (5Y)4.04
EPS Next 2Y22.87%
EPS Next 3Y14.18%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.79%, DEA is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.44, DEA pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.35, DEA pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.79%

5.2 History

On average, the dividend of DEA grows each year by 18.09%, which is quite nice.
DEA has been paying a dividend for at least 10 years, so it has a reliable track record.
DEA has decreased its dividend recently.
Dividend Growth(5Y)18.09%
Div Incr Years0
Div Non Decr Years1
DEA Yearly Dividends per shareDEA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

DEA pays out 673.49% of its income as dividend. This is not a sustainable payout ratio.
The dividend of DEA is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP673.49%
EPS Next 2Y22.87%
EPS Next 3Y14.18%
DEA Yearly Income VS Free CF VS DividendDEA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M
DEA Dividend Payout.DEA Dividend Payout, showing the Payout Ratio.DEA Dividend Payout.PayoutRetained Earnings

EASTERLY GOVERNMENT PROPERTI

NYSE:DEA (7/11/2025, 8:05:00 PM)

After market: 23.24 0 (0%)

23.24

+0.13 (+0.56%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)04-29 2025-04-29/bmo
Earnings (Next)07-29 2025-07-29
Inst Owners79.34%
Inst Owner Change0%
Ins Owners6.03%
Ins Owner Change0.35%
Market Cap1.04B
Analysts51.43
Price Target23.72 (2.07%)
Short Float %3.76%
Short Ratio2.15
Dividend
Industry RankSector Rank
Dividend Yield 7.79%
Yearly Dividend2.77
Dividend Growth(5Y)18.09%
DP673.49%
Div Incr Years0
Div Non Decr Years1
Ex-Date05-05 2025-05-05 (0.45)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-44.77%
Min EPS beat(2)-44.99%
Max EPS beat(2)-44.55%
EPS beat(4)0
Avg EPS beat(4)-27.83%
Min EPS beat(4)-44.99%
Max EPS beat(4)-0.99%
EPS beat(8)0
Avg EPS beat(8)-22.36%
EPS beat(12)2
Avg EPS beat(12)0.33%
EPS beat(16)2
Avg EPS beat(16)-3.33%
Revenue beat(2)0
Avg Revenue beat(2)-2.55%
Min Revenue beat(2)-2.57%
Max Revenue beat(2)-2.53%
Revenue beat(4)0
Avg Revenue beat(4)-2.18%
Min Revenue beat(4)-3.47%
Max Revenue beat(4)-0.15%
Revenue beat(8)1
Avg Revenue beat(8)-1.75%
Revenue beat(12)2
Avg Revenue beat(12)-1.54%
Revenue beat(16)3
Avg Revenue beat(16)-1.54%
PT rev (1m)-6.38%
PT rev (3m)93.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)100%
EPS NY rev (1m)-9.58%
EPS NY rev (3m)126.04%
Revenue NQ rev (1m)0.4%
Revenue NQ rev (3m)1.27%
Revenue NY rev (1m)0.37%
Revenue NY rev (3m)0.87%
Valuation
Industry RankSector Rank
PE 55.33
Fwd PE 32.41
P/S 3.39
P/FCF 357.23
P/OCF 6.4
P/B 0.78
P/tB 0.89
EV/EBITDA 14.61
EPS(TTM)0.42
EY1.81%
EPS(NY)0.72
Fwd EY3.09%
FCF(TTM)0.07
FCFY0.28%
OCF(TTM)3.63
OCFY15.61%
SpS6.86
BVpS29.7
TBVpS26.24
PEG (NY)3.6
PEG (5Y)4.04
Profitability
Industry RankSector Rank
ROA 0.54%
ROE 1.31%
ROCE 2.59%
ROIC 2.04%
ROICexc 2.05%
ROICexgc 2.16%
OM 26.33%
PM (TTM) 5.66%
GM 66.87%
FCFM 0.95%
ROA(3y)0.77%
ROA(5y)0.77%
ROE(3y)1.77%
ROE(5y)1.72%
ROIC(3y)1.98%
ROIC(5y)1.97%
ROICexc(3y)1.99%
ROICexc(5y)1.98%
ROICexgc(3y)2.11%
ROICexgc(5y)2.1%
ROCE(3y)2.51%
ROCE(5y)2.49%
ROICexcg growth 3Y-1.96%
ROICexcg growth 5Y7.64%
ROICexc growth 3Y-1.42%
ROICexc growth 5Y8.25%
OM growth 3Y-0.6%
OM growth 5Y9.25%
PM growth 3Y-16.41%
PM growth 5Y14.45%
GM growth 3Y-0.86%
GM growth 5Y-0.31%
F-Score4
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 1.2
Debt/FCF 548.15
Debt/EBITDA 8.87
Cap/Depr 161.09%
Cap/Sales 51.96%
Interest Coverage 1.34
Cash Conversion 90.31%
Profit Quality 16.75%
Current Ratio 0.87
Quick Ratio 0.87
Altman-Z 0.25
F-Score4
WACC6.48%
ROIC/WACC0.32
Cap/Depr(3y)81.03%
Cap/Depr(5y)66.9%
Cap/Sales(3y)26.01%
Cap/Sales(5y)22.34%
Profit Quality(3y)243.21%
Profit Quality(5y)353.51%
High Growth Momentum
Growth
EPS 1Y (TTM)-16%
EPS 3Y-18.42%
EPS 5Y13.7%
EPS Q2Q%-44%
EPS Next Y15.35%
EPS Next 2Y22.87%
EPS Next 3Y14.18%
EPS Next 5YN/A
Revenue 1Y (TTM)6.62%
Revenue growth 3Y3.19%
Revenue growth 5Y6.38%
Sales Q2Q%8.07%
Revenue Next Year9.31%
Revenue Next 2Y8.93%
Revenue Next 3Y8.49%
Revenue Next 5Y7.62%
EBIT growth 1Y18.16%
EBIT growth 3Y2.57%
EBIT growth 5Y16.22%
EBIT Next Year156.64%
EBIT Next 3Y41.46%
EBIT Next 5YN/A
FCF growth 1Y-96.52%
FCF growth 3Y-50.88%
FCF growth 5Y-31.59%
OCF growth 1Y32.03%
OCF growth 3Y11.19%
OCF growth 5Y2.71%